ImmuCell Corp. of Portland has received a $210,000 payment from Univax Biologics

Authors

Source

Portland Press Herald

Date

6-2-1994

Pages

10B

Abstract

ImmuCell Corp. of Portland has received a $210,000 payment from Univax Biologics Inc. of Rockville, Md., toward the development of CryptoGAM, a milk-based drug that fights infection in AIDS patients. Univax since 1992 has provided a total of $850,000 to ImmuCell and underwritten the cost of clinical trials for the antibody treatment. The anitbody fights cryptosporidium parvum, a bacterium that causes chronic and life-threatening diarrhea in many patients with AIDS.

Subjects

AIDS (Disease), Biotechnology industries, ImmuCell Corp -- Portland

Recommended Citation

"ImmuCell Corp. of Portland has received a $210,000 payment from Univax Biologics" (1994). Maine News Index – Portland Press Herald. 13138.
https://digitalcommons.portlandlibrary.com/news_pph/13138